{"id":"https://openalex.org/W7204732465","doi":"https://doi.org/10.1016/s2152-2650(26)02021-5","title":"CLL-179: Real-World Pharmacovigilance Assessment of Hematologic Safety Signals Among Bruton Tyrosine Kinase Inhibitors, Including Pirtobrutinib: Insights From the Food and Drug Administration Adverse Event Reporting System","display_name":"CLL-179: Real-World Pharmacovigilance Assessment of Hematologic Safety Signals Among Bruton Tyrosine Kinase Inhibitors, Including Pirtobrutinib: Insights From the Food and Drug Administration Adverse Event Reporting System","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204732465","doi":"https://doi.org/10.1016/s2152-2650(26)02021-5"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)02021-5","doi":"https://doi.org/10.1016/s2152-2650(26)02021-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02021-5","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Quoc Hoang Pham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405284280","display_name":"International University of Health and Welfare Narita Hospital","ror":"https://ror.org/03979n059","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284280"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Quoc Hoang Pham","raw_affiliation_strings":["International University of Health and Welfare Narita Hospital, Narita, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International University of Health and Welfare Narita Hospital, Narita, Japan","institution_ids":["https://openalex.org/I4405284280"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120359174","display_name":"Klesta Cocoli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Klesta Cocoli","raw_affiliation_strings":["NYMC/Landmark Medical Center Department of Internal Medicine, Woonsocket, RI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYMC/Landmark Medical Center Department of Internal Medicine, Woonsocket, RI, USA","institution_ids":["https://openalex.org/I181190671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148699705","display_name":"Hammad Assilkhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42317466","display_name":"Alt\u0131nba\u015f University","ror":"https://ror.org/0145w8333","country_code":"TR","type":"education","lineage":["https://openalex.org/I42317466"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Hammad Assilkhi","raw_affiliation_strings":["Alt\u0131nba\u015f University, Faculty of Medicine, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alt\u0131nba\u015f University, Faculty of Medicine, Istanbul, Turkey","institution_ids":["https://openalex.org/I42317466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148625565","display_name":"Haniyah Gul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I152236710","display_name":"Foundation University Islamabad","ror":"https://ror.org/0130a6s10","country_code":"PK","type":"education","lineage":["https://openalex.org/I152236710"]},{"id":"https://openalex.org/I2801712768","display_name":"Foundation University Medical College","ror":"https://ror.org/020jkns84","country_code":"PK","type":"education","lineage":["https://openalex.org/I2801712768"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Haniyah Gul","raw_affiliation_strings":["Foundation University Medical College, Islamabad, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation University Medical College, Islamabad, Pakistan","institution_ids":["https://openalex.org/I152236710","https://openalex.org/I2801712768"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148744214","display_name":"Sima Jabri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42317466","display_name":"Alt\u0131nba\u015f University","ror":"https://ror.org/0145w8333","country_code":"TR","type":"education","lineage":["https://openalex.org/I42317466"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Sima Jabri","raw_affiliation_strings":["Alt\u0131nba\u015fUniversity, Faculty of Medicine, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alt\u0131nba\u015fUniversity, Faculty of Medicine, Istanbul, Turkey","institution_ids":["https://openalex.org/I42317466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117937109","display_name":"Nour Elghoul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60342839","display_name":"Qatar University","ror":"https://ror.org/00yhnba62","country_code":"QA","type":"education","lineage":["https://openalex.org/I60342839"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Nour Elghoul","raw_affiliation_strings":["College of Medicine, QU Health Sector, Qatar University, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medicine, QU Health Sector, Qatar University, Doha, Qatar","institution_ids":["https://openalex.org/I60342839"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092636882","display_name":"Shreya Singh Beniwal","orcid":"https://orcid.org/0009-0001-7073-8639","observed_orcids":["https://orcid.org/0009-0001-7073-8639"]},"institutions":[{"id":"https://openalex.org/I114546181","display_name":"Lady Hardinge Medical College","ror":"https://ror.org/03x8jdc94","country_code":"IN","type":"education","lineage":["https://openalex.org/I110166357","https://openalex.org/I114546181"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shreya Singh Beniwal","raw_affiliation_strings":["Lady Hardinge Medical College, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lady Hardinge Medical College, New Delhi, India","institution_ids":["https://openalex.org/I114546181"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5141283320","display_name":"Anushka Anand Hanchate","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801183603","display_name":"Mahatma Gandhi Memorial Medical College","ror":"https://ror.org/0223apb60","country_code":"IN","type":"education","lineage":["https://openalex.org/I138272832","https://openalex.org/I2801183603"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Anushka Anand Hanchate","raw_affiliation_strings":["MGM Medical College, Kamothe, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MGM Medical College, Kamothe, India","institution_ids":["https://openalex.org/I2801183603"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S595","last_page":"S595"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.24490000307559967,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9470000267028809},{"id":"https://openalex.org/keywords/pirtobrutinib","display_name":"pirtobrutinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9589999914169312},{"id":"https://openalex.org/keywords/acalabrutinib","display_name":"acalabrutinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/zanubrutinib","display_name":"zanubrutinib","score":1.0},{"id":"https://openalex.org/keywords/hematological-adverse-events","display_name":"hematologic adverse events","score":0.8849999904632568},{"id":"https://openalex.org/keywords/cytopenia","display_name":"cytopenia","score":0.5989999771118164},{"id":"https://openalex.org/keywords/pure-red-cell-aplasia","display_name":"pure red cell aplasia","score":0.9150000214576721},{"id":"https://openalex.org/keywords/aplastic-anemia","display_name":"aplastic anemia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/hemorrhage","display_name":"hemorrhage","score":0.8859999775886536},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.7910000085830688},{"id":"https://openalex.org/keywords/small-lymphocytic-lymphoma","display_name":"small lymphocytic lymphoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9688000082969666},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8960000276565552},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.8919000029563904},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.7508000135421753},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.660099983215332},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5026999711990356},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.4984999895095825},{"id":"https://openalex.org/C3020169349","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug event","level":3,"score":0.4966000020503998},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4219000041484833},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.41690000891685486},{"id":"https://openalex.org/C2779662365","wikidata":"https://www.wikidata.org/wiki/Q5416694","display_name":"Event (particle physics)","level":2,"score":0.4056999981403351},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.3986999988555908},{"id":"https://openalex.org/C2777488183","wikidata":"https://www.wikidata.org/wiki/Q6900510","display_name":"Safety monitoring","level":2,"score":0.3716999888420105},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.35120001435279846},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34209999442100525},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3393000066280365},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3294999897480011},{"id":"https://openalex.org/C2987276129","wikidata":"https://www.wikidata.org/wiki/Q12140","display_name":"Drug administration","level":2,"score":0.32179999351501465},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.31610000133514404},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.2782000005245209},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.25949999690055847}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)02021-5","doi":"https://doi.org/10.1016/s2152-2650(26)02021-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02021-5","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7208736203","https://openalex.org/W7204684514","https://openalex.org/W7204722399","https://openalex.org/W4308939583","https://openalex.org/W7169873875","https://openalex.org/W7204702479","https://openalex.org/W4393899188","https://openalex.org/W4310127249","https://openalex.org/W7213322729","https://openalex.org/W4399322024"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-31T00:00:00"}